Why is Sanofi Consumer Healthcare India Ltd ?
1
With ROE of 83.6, it has a Very Expensive valuation with a 41.8 Price to Book Value
- Over the past year, while the stock has generated a return of -1.96%, its profits have fallen by -27%
2
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -1.96% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Sanofi Consumer should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sanofi Consumer for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sanofi Consumer
-5.85%
-0.06
30.16%
Sensex
-4.3%
0.44
11.83%
Quality key factors
Factor
Value
Sales Growth (5y)
21.20%
EBIT Growth (5y)
11.72%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.73
Sales to Capital Employed (avg)
2.77
Tax Ratio
25.04%
Dividend Payout Ratio
69.89%
Pledged Shares
0
Institutional Holding
20.16%
ROCE (avg)
-178.66%
ROE (avg)
76.98%
Valuation Key Factors 
Factor
Value
P/E Ratio
45
Industry P/E
31
Price to Book Value
40.70
EV to EBIT
34.55
EV to EBITDA
33.24
EV to Capital Employed
150.17
EV to Sales
11.69
PEG Ratio
2.70
Dividend Yield
1.21%
ROCE (Latest)
368.27%
ROE (Latest)
91.45%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
Technical Movement
24What is working for the Company
NET SALES(Q)
Highest at Rs 251.00 cr
PBDIT(Q)
Highest at Rs 89.80 cr.
PBT LESS OI(Q)
Highest at Rs 85.90 cr.
PAT(Q)
Highest at Rs 66.50 cr.
EPS(Q)
Highest at Rs 28.91
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Sanofi Consumer
Net Sales - Quarterly
Highest at Rs 251.00 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 89.80 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 85.90 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 66.50 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 251.00 cr has Grown at 25.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 199.53 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 85.90 cr has Grown at 27.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 67.53 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 66.50 cr has Grown at 23.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 53.72 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 28.91
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)